Mottola Frank

CIK 00018045671 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001804567

Recent Transactions

50 trades

Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-12-19$39.40/sh+5,000→ 20,496 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-12-19−15,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-12-19−5,000→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-12-19$50.47/sh−15,000→ 15,496 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-12-19$25.30/sh+15,000→ 30,496 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-12-19$50.22/sh−5,000→ 15,496 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-12$45.87/sh−5,000→ 15,496 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-09-12−5,000→ 5,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-12$39.40/sh+5,000→ 20,496 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-25$44.51/sh−14,000→ 15,496 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-25$12.98/sh+14,000→ 29,496 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-08-25−14,000→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-07$39.11/sh−1,356→ 15,151 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-03-07−2,625→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-07+2,625→ 16,507 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−945→ 13,882 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−337→ 15,437 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−610→ 14,827 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-26−3,750→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-26−2,010→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-26$39.48/sh−976→ 13,933 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-26$39.48/sh−1,909→ 15,774 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-26+3,750→ 17,683 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-26+2,010→ 14,909 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-23+1,875→ 12,899 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-23−1,875→ 3,750 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−750→ 750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+750→ 9,774 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+1,250→ 11,024 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−1,250→ 3,750 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-21−1,125→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21+1,125→ 9,576 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21$39.15/sh−552→ 9,024 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,500→ 4,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-02-19+20,000→ 20,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-17+2,625→ 2,625 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-05+2,010→ 2,010 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-05+3,750→ 3,750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-01-28+1,125→ 1,125 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-11-07−15,000→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-11-07$36.98/sh−15,000→ 8,200 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-11-07$9.13/sh+15,000→ 23,200 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-02-28−990→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-28$27.94/sh−460→ 7,779 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-28+990→ 8,239 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+1,875→ 8,186 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23$29.06/sh−937→ 7,249 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−1,875→ 5,625 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22+5,000→ 5,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22+750→ 6,646 total

Companies

SUPERNUS PHARMACEUTICALS, INC.
SVP, Quality, GMP, Ops, IT
$SUPN

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov